Skip to main content
SpringerLink
Log in

Epidemiology of Drug-Resistant Tuberculosis

  • Chapter
  • First Online:
Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1019))

Abstract

As we move into the era of the Sustainable Development Goals (SDGs), the World Health Organization (WHO) has developed the End TB strategy 2016–2035 with a goal to end the global epidemic of tuberculosis (TB) by 2035. Achieving the targets laid out in the Strategy will require strengthening of the whole TB diagnosis and treatment cascade, including improved case detection, the establishment of universal drug susceptibility testing and rapid treatment initiation. An estimated 3.9% of new TB cases and 21% of previously treated cases had rifampicin-resistant (RR) or multidrug-resistant (MDR) TB in 2015. These levels have remained stable over time, although limited data are available from major high burden settings. In addition to the emergence of drug resistance due to inadequate treatment, there is growing evidence that direct transmission is a large contributor to the RR/MDR-TB epidemic. Only 340,000 of the estimated 580,000 incident cases of RR/MDR-TB were notified to WHO in 2015. Among these, only 125,000 were initiated on second-line treatment. RR/MDR-TB epidemics are likely to be driven by direct transmission. The most important risk factor for MDR-TB is a history of previous treatment. Other risk factors vary according to setting but can include hospitalisation, incarceration and HIV infection. Children have the same risk of MDR-TB as adults and represent a diagnostic and treatment challenge. Rapid molecular technologies have revolutionized the diagnosis of drug-resistant TB. Until capacity can be established to test every TB patient for rifampicin resistance, countries should focus on gradually expanding their coverage of testing. DNA sequencing technologies are being increasingly incorporated into patient management and drug resistance surveillance. They offer additional benefits over conventional culture-based phenotypic testing, including a faster turn-around time for results, assessment of resistance patterns to a range of drugs, and investigation of strain clustering and transmission.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aia P, Kal M, Lavu E et al (2016) The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS One 11:e0149806. doi:10.1371/journal.pone.0149806

    Article  PubMed  PubMed Central  Google Scholar 

  • Almeida D, Rodrigues C, Ashavaid TF et al (2005) High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 40:881–886

    Article  PubMed  Google Scholar 

  • Billington OJ, McHugh TD, Gillespie SH (1999) Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 43:1866–1869

    CAS  PubMed  PubMed Central  Google Scholar 

  • Blower SM, Chou T (2004) Modeling the emergence of the “hot zones”: tuberculosis and the amplification dynamics of drug resistance. Nat Med 10:1111–1116

    Article  CAS  PubMed  Google Scholar 

  • Borgdorff MW (2004) New measurable indicator for tuberculosis case detection. Emerg Infect Dis 10:1523–1528. doi:10.3201/eid1009.040349

    Article  PubMed  PubMed Central  Google Scholar 

  • Caminero JA (2008) Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation. Int J Tuberc Lung Dis 12:869–877

    CAS  PubMed  Google Scholar 

  • Centers for Disease Control (CDC) (1991) Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons – Florida and New York, 1988–1991. MMWR Morb Mortal Wkly Rep 40:585–591

    Google Scholar 

  • Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 10:1117–1121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen T, Colijn C, Finklea B et al (2008) Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One 3:e2363. doi:10.1371/journal.pone.0002363

    Article  PubMed  PubMed Central  Google Scholar 

  • Cohen T, Hedt BL, Pagano M (2010) Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study. BMC Public Health 10:355. doi:10.1186/1471-2458-10-355

    Article  PubMed  PubMed Central  Google Scholar 

  • Cohen T, Jenkins HE, Lu C et al (2014) On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data. Drug Resist Updat 17:105–123. doi:10.1016/j.drup.2014.10.001

    Article  PubMed  PubMed Central  Google Scholar 

  • Coninx R, Maher D, Reyes H, Grzemska M (2000) Tuberculosis in prisons in countries with high prevalence. BMJ 320:440–442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coronado VG, Beck-Sague CM, Hutton MD et al (1993) Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 168:1052–1055

    Article  CAS  PubMed  Google Scholar 

  • Cox HS, McDermid C, Azevedo V et al (2010) Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 5:e13901. doi:10.1371/journal.pone.0013901

    Article  PubMed  PubMed Central  Google Scholar 

  • Crofton J, Mitchison DA (1948) Streptomycin resistance in pulmonary tuberculosis. BMJ 2:1009–1015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dean AS, Zignol M, Falzon D et al (2014) HIV and multidrug-resistant tuberculosis: overlapping epidemics. Eur Respir J 44:251–254. doi:10.1183/09031936.00205413

    Article  PubMed  Google Scholar 

  • Dye C, Williams BG (2000) Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U S A 97:8180–8185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edlin BR, Tokars JI, Grieco MH et al (1992) An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 326:1514–1521. doi:10.1056/NEJM199206043262302

    Article  CAS  PubMed  Google Scholar 

  • Frieden TR, Sterling T, Pablos-Mendez A et al (1993) The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 328:521–526. doi:10.1056/NEJM199302253280801

    Article  CAS  PubMed  Google Scholar 

  • Frieden TR, Sherman LF, Maw KL et al (1996) A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276:1229–1235

    Article  CAS  PubMed  Google Scholar 

  • Gagneux S, Burgos MV, DeRiemer K et al (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2:e61. doi:10.1371/journal.ppat.0020061

    Article  PubMed  PubMed Central  Google Scholar 

  • Gandhi NR, Moll A, Sturm AW et al (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575–1580

    Article  PubMed  Google Scholar 

  • Gandhi NR, Weissman D, Moodley P et al (2013) Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 207:9–17. doi:10.1093/infdis/jis631

    Article  PubMed  Google Scholar 

  • Gelmanova IY, Keshavjee S, Golubchikova VT et al (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 85:703–711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guerra-Assunção JA, Crampin AC, RMGJ H et al (2015) Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. Elife. doi:10.7554/eLife.05166

  • Habeenzu C, Mitarai S, Lubasi D et al (2007) Tuberculosis and multidrug resistance in Zambian prisons, 2000–2001. Int J Tuberc Lung Dis 11:1216–1220

    CAS  PubMed  Google Scholar 

  • Heidebrecht CL, Podewils LJ, Pym A et al (2016) Assessing loval risk of rifampicin-resistant tuberculosis in KwaZulu-Natal, South Africa using lot quality assurance sampling. PLoS One 11:e0153143

    Article  PubMed  PubMed Central  Google Scholar 

  • Jenkins HE, Plesca V, Ciobanu A et al (2013) Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J 42:1291–1301. doi:10.1183/09031936.00111812

    Article  PubMed  Google Scholar 

  • Jenkins HE, Gegia M, Furin J et al (2014a) Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Euro Surveill 19:20743

    Article  PubMed  PubMed Central  Google Scholar 

  • Jenkins HE, Tolman AW, Yuen CM et al (2014b) Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 383:1572–1579. doi:10.1016/S0140-6736(14)60195-1

    Article  PubMed  PubMed Central  Google Scholar 

  • Kendall EA, Fofana MO, Dowdy DW (2015) Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med 3:963–972. doi:10.1016/S2213-2600(15)00458-0

    Article  PubMed  PubMed Central  Google Scholar 

  • Kimerling ME, Kluge H, Vezhnina N et al (1999) Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 3:451–453

    CAS  PubMed  Google Scholar 

  • Klopper M, Warren RM, Hayes C et al (2013) Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 19:449–455. doi:10.3201//EID1903.120246

    Article  PubMed  PubMed Central  Google Scholar 

  • Lukoye D, Ssengooba W, Musisi K et al (2015) Variation and risk factors of drug resistant tuberculosis in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 15:291. doi:10.1186/s12889-015-1614-8

    Article  PubMed  PubMed Central  Google Scholar 

  • Mesfin YM, Hailemariam D, Biadglign S, Kibret KT (2014) Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One 9:e82235. doi:10.1371/journal.pone.0082235

    Article  PubMed  PubMed Central  Google Scholar 

  • Mlambo CK, Warren RM, Poswa X et al (2008) Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 12:99–104

    CAS  PubMed  Google Scholar 

  • Monno L, Angarano G, Carbonara S et al (1991) Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet 337:852

    Article  CAS  PubMed  Google Scholar 

  • Murase Y, Maeda S, Yamada H et al (2010) Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 16:948–954. doi:10.3201/eid1606.091844

    Article  PubMed  PubMed Central  Google Scholar 

  • Nardell E, Dharmadhikari A (2010) Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 14:1233–1243

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nodieva A, Jansone I, Broka L et al (2010) Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 14:427–433

    CAS  PubMed  Google Scholar 

  • Pablos-Méndez A, Raviglione MC, Laszlo A et al (1998) Global surveillance for antituberculosis-drug resistance, 1994–1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338:1641–1649. doi:10.1056/NEJM199806043382301

    Article  PubMed  Google Scholar 

  • Paramasivan CN, Venkataraman P (2004) Drug resistance in tuberculosis in India. Indian J Med Res 120:377–386

    CAS  PubMed  Google Scholar 

  • Perdigao J, Macedo R, Malaquias A et al (2010) Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J Antimicrob Chemother 65:224–227. doi:10.1093/jac/dkp452

    Article  CAS  PubMed  Google Scholar 

  • Rifat M, Hall J, Oldmeadow C et al (2015) Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open 5:e008273. doi:10.1136/bmjopen-2015-008273

    Article  PubMed  PubMed Central  Google Scholar 

  • Rigouts L, Nolasco O, de Rijk P et al (2007) Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 45:252–254. doi:10.1128/JCM.01489-06

    Article  CAS  PubMed  Google Scholar 

  • Roetzer A, Diel R, Kohl TA et al (2013) Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 10:e1001387. doi:10.1371/journal.pmed.1001387

    Article  PubMed  PubMed Central  Google Scholar 

  • Schnippel K, Meyer-Rath G, Long L et al (2013) Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J 103:101–106. doi:10.7196/samj.6182

    Article  CAS  PubMed  Google Scholar 

  • Shenoi SV, Escombe AR, Friedland G (2010) Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts. Clin Infect Dis 50(Suppl 3):S231–S237. doi:10.1086/651496

    Article  PubMed  PubMed Central  Google Scholar 

  • Stuckler D, Basu S, Mckee M, King L (2008) Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. P Natl Acad Sci USA 105:13280–13285. doi:10.1073/pnas.0801200105

    Article  CAS  Google Scholar 

  • Ulmasova D, Uzakova G, Tillyashayhov M et al (2013) Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Euro Surveill. doi:20609 [pii]

  • Uplekar M, Weil D, Lonnroth K et al (2015) WHO’s new end TB strategy. Lancet 385:1799–1801. doi:10.1016/S0140-6736(15)60570-0

    Article  PubMed  Google Scholar 

  • van den Hof S, Tursynbayeva A, Abildaev T et al (2015) HIV and multidrug-resistant tuberculosis: overlapping risk factors. Eur Respir J 45:567–569. doi:10.1183/09031936.00131014

    Article  PubMed  Google Scholar 

  • Wells CD, Cegielski JP, Nelson LJ et al (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196(Suppl 1):S86–107. doi:10.1086/518665

    Article  PubMed  Google Scholar 

  • World Health Organization (2013) The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Interim policy guidance. WHO/HTM/TB/2013.6. Geneva

    Google Scholar 

  • World Health Organization (2014a) Drug-resistant TB – surveillance and response. Supplement to global tuberculosis report 2014. WHO/HQ/TB/2014.12. Geneva

    Google Scholar 

  • World Health Organization (2014b) Global tuberculosis report 2014. WHO/HTM/TB/2014.08. Geneva

    Google Scholar 

  • World Health Organization (2014c) Xpert MTB/RIF implementation manual. Technical and operational “how-to”: practical considerations

    Google Scholar 

  • World Health Organization (2014d) The use of delamanid in the treatment of multidrug-resistant tuberculosis. WHO/HTM/TB2014.23. Geneva

    Google Scholar 

  • World Health Organization (2016) Global tuberculosis report 2015. Geneva

    Google Scholar 

  • World Health Organization WHO End TB Strategy. http://www.who.int/tb/post2015_strategy/en

  • Zelner JL, Murray MB, Becerra MC et al (2016) Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. J Infect Dis 213:287–294. doi:10.1093/infdis/jiv387

    Article  PubMed  Google Scholar 

  • Zhao Y, Xu S, Wang L et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366:2161–2170. doi:10.1056/NEJMoa1108789

    Article  CAS  PubMed  Google Scholar 

  • Zignol M, Sismanidis C, Falzon D et al (2013) Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 42:701–707. doi:10.1183/09031936.00175812

    Article  PubMed  Google Scholar 

  • Zignol M, Dean A, Falzon D, et al (2016) Twenty years of global surveillance of anti-tuberculosis drug resistance: key achievements and findings, remaining challenges, future direction

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Global TB Programme, World Health Organization, Geneva, Switzerland

    Anna S. Dean & Matteo Zignol

  2. Division of Medical Microbiology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

    Helen Cox

Authors
  1. Anna S. Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen Cox
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matteo Zignol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna S. Dean .

Editor information

Editors and Affiliations

  1. Swiss Tropical & Public Health Institute, University of Basel, Basel, Switzerland

    Sebastien Gagneux

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dean, A.S., Cox, H., Zignol, M. (2017). Epidemiology of Drug-Resistant Tuberculosis. In: Gagneux, S. (eds) Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control. Advances in Experimental Medicine and Biology, vol 1019. Springer, Cham. https://doi.org/10.1007/978-3-319-64371-7_11

Download citation

Publish with us

Policies and ethics

Search

Navigation